Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.53), $0.02 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $379 thousand versus the consensus estimate of $360 thousand.

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.